medicalnewstoday.com
May 16, 2008
St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of the IsoFlex® Optim™ pacing lead. The small-diameter lead is built on the proven IsoFlex® pacing lead platform, and features the company's exclusive Optim® insulation material....
[read full story]